Skip to content
Back

Marc S. Stieglitz, PhD

Director Preclinical Development

Curriculum Vitae Marc S. Stieglitz

Marc Stieglitz graduated as neuroscientist at the University of Regensburg before pursuing his PhD in pharmacology at the Ludwig-Maximilians-University Munich. After his time as postdoctoral researcher he joined a small biotechnology company focused on the development of gene therapies for inherited retinal diseases, where he grew to be a cross-functional leader of gene therapy drug development programs. He was a key player in advancing two treatments to clinical testing in just five years. In December 2024 he joined the DEBRA Research team as Director Preclinical Development.

Back to main navigation